<DOC>
	<DOCNO>NCT00693706</DOCNO>
	<brief_summary>The purpose study compare safety &amp; immune response single dose GSK Biologicals ' cell-culture base influenza vaccine 138842A US license , egg-based trivalent influenza vaccine [ Fluarix ] healthy adult .</brief_summary>
	<brief_title>Safety Immune Response Study GSK Biologicals ' Influenza Virus Vaccine 1388442A Compared With Fluarix</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol A male nonpregnant , nonlactating female 18 49 year age time vaccination Access telephone schedule followup telephone contact Ability provide write informed consent Healthy subject establish medical history physical examination enter study If subject female , must nonchildbearing potential , childbearing potential , must practice adequate contraception 30 day prior vaccination continue precaution 2 month receipt study vaccine . All woman pregnancy test day vaccination . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede dose study vaccine , plan use study period Receipt systemic glucocorticoid within 30 day study enrollment Administration immunosuppressant , cytotoxic , immunemodifying drug ( glucocorticoid ) irradiation within 6 month prior study enrollment plan administration study period Administration immunoglobulins and/or blood product within 3 month prior study enrollment plan administration study period Previous vaccination influenza ( 20072008 influenza season ) History anaphylactic allergic reaction influenza vaccine , vaccine , vaccine component excipient History GuillainBarre Syndrome ( GBS ) Acute disease , febrile illness , upper respiratory infection screen . History splenectomy Any confirm suspect , acquire , congenital , hereditary immunodeficiency immunosuppressive condition ( include human immunodeficiency virus [ HIV ] ) base medical history physical examination Acquired congenital coagulation disorder know thrombocytopenia Current treatment warfarin heparin derivative Known use analgesic antipyretic medication within 12 hour prior treatment purpose prophylaxis adverse event Any medical condition US Advisory Committee Immunization Practices recommend vaccination influenza</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cell culture</keyword>
	<keyword>Safety</keyword>
	<keyword>Influenza</keyword>
	<keyword>Humans</keyword>
	<keyword>Adults</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Vaccine</keyword>
</DOC>